10.1007/s40204-019-0118-5

Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles

HTML PDF
  • Chinmay G. Hiremath1,
  • Geetha B. Heggnnavar2,
  • Mahadevappa Y. Kariduraganavar2,
  • Murigendra B. Hiremath*1,
  1. Department of Biotechnology and Microbiology, Karnatak University, Dharwad, Karnataka, 580003, IN
  2. Department of Chemistry, Karnatak University, Dharwad, Karnataka, 580003, IN
Cover Image

Published in Issue 2019-06-13

How to Cite

Hiremath, C. G., Heggnnavar, G. B., Kariduraganavar, M. Y., & Hiremath, M. B. (2019). Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using Pluronic-coated iron oxide nanoparticles. Progress in Biomaterials, 8(3 (September 2019). https://doi.org/10.1007/s40204-019-0118-5
Crossref
Scopus
Google Scholar
Europe PMC

Abstract

Abstract Active targeting of folic acid and passive targeting of magnetic nanoparticles to bring about co-delivery of hydrophobic chemotherapeutic agents were the focus of this work. Co-precipitation in alkaline environment was employed for synthesizing Fe 3 O 4 nanoparticles and stabilized by oleic acid. Aqueous dispersibility of oleic acid coated nanoparticles was brought about by folic acid modified Pluronic F127 and Pluronic F127 mixture. Folic acid is used as a targeting agent which was joined to Pluronic F127 via diethylene glycol bis(3-aminopropyl) ether spacer. The nanocomposite was used to delivery hydrophobic anticancer drugs, paclitaxel, and curcumin. Successful modification at each step was confirmed by FTIR and NMR. Quantitative analysis of attached folic acid indicated a total of 84.34% amount of conjugation. Nanoparticles characterization revealed the hydrodynamic size of and nanocomposite to be 94.2 nm nanometres. Furthermore, transmission electron micrograph reveals the size of the nanoparticle to be 12.5 nm hence also shows the superparamagnetic activity. Drug encapsulation efficiency of 34.7% and 59.5% was noted for paclitaxel and curcumin, respectively. Cytotoxic property of drug-loaded nanocomposites was increased in case of folic acid functionalized nanoparticles and further increased in the presence of an external magnetic field. Cellular uptake increased in the folic acid conjugated sample. Further many folds in the presence of an external magnetic field. Graphic abstract

Keywords

  • Pluronic,
  • Magnetic nanoparticles,
  • Folic acid,
  • Curcumin,
  • Paclitaxel
HTML PDF

References

  1. Arya et al. (2011) Enhanced antiproliferative activity of Herceptin (HER2)-conjugated gemcitabine-loaded chitosan nanoparticle in pancreatic cancer therapy (pp. 859-870) https://doi.org/10.1016/j.nano.2011.03.009
  2. Batrakova et al. (2005) Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery (pp. 793-802) https://doi.org/10.1021/bc049730c
  3. Brash (2018) Blood compatibility of nanomaterials (pp. 13-31) https://doi.org/10.1016/B978-0-323-50922-0.00002-X
  4. Brigger et al. (2002) Nanoparticles in cancer therapy and diagnosis (pp. 631-651) https://doi.org/10.1016/S0169-409X(02)00044-3
  5. Chauhan and Jain (2013) Strategies for advancing cancer nanomedicine (pp. 958-962) https://doi.org/10.1038/nmat3792
  6. Cheung et al. (2016) Targeting folate receptor alpha for cancer treatment (pp. 52553-52574) https://doi.org/10.18632/oncotarget.9651
  7. Din et al. (2017) Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors (pp. 7291-7309) https://doi.org/10.2147/ijn.s146315
  8. Dinda et al. (2012) Cellular interaction of folic acid conjugated superparamagnetic iron oxide nanoparticles and its use as contrast agent for targeted magnetic imaging of tumor cells https://doi.org/10.2147/IJN.S32694
  9. Fujita et al. (1999) Thermally induced localization of cyclodextrins in a polyrotaxane consisting of β-cyclodextrins and poly(ethylene glycol)–poly(propylene glycol) triblock copolymer https://doi.org/10.1021/ma9814550
  10. Ganta and Amiji (2009) Coadministration of paclitaxel and curcumin in nanoemulsion formulations to overcome multidrug resistance in tumor cells (pp. 928-939) https://doi.org/10.1021/mp800240j
  11. Gottesman et al. (2002) Multidrug resistance in cancer: role of ATP–dependent transporters (pp. 48-58) https://doi.org/10.1038/nrc706
  12. Gupta and Gupta (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications (pp. 3995-4021) https://doi.org/10.1016/j.biomaterials.2004.10.012
  13. Hamzehalipour Almaki et al. (2017) Trastuzumab-decorated nanoparticles for in vitro and in vivo tumor-targeting hyperthermia of HER2+ breast cancer (pp. 7369-7383) https://doi.org/10.1039/C7TB01305A
  14. Hatcher et al. (2008) Curcumin: from ancient medicine to current clinical trials (pp. 1631-1652) https://doi.org/10.1007/s00018-008-7452-4
  15. Hiremath et al. (2018) Synergistic delivery of 5-fluorouracil and curcumin using human serum albumin-coated iron oxide nanoparticles by folic acid targeting (pp. 297-306) https://doi.org/10.1007/s40204-018-0104-3
  16. Huang et al. (1988) Inhibitory effect of curcumin, chlorogenic acid, caffeic acid, and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate (pp. 5941-5946)
  17. Huang et al. (2009) Folate-mediated chondroitin sulfate-Pluronic 127 nanogels as a drug carrier (pp. 64-73) https://doi.org/10.1016/j.ejps.2009.06.002
  18. Jain et al. (2008) Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging (pp. 4012-4021) https://doi.org/10.1016/j.biomaterials.2008.07.004
  19. Jin et al. (2010) Multifunctional nanoparticles as coupled contrast agents (pp. 1-8) https://doi.org/10.1038/ncomms1042
  20. Kang et al. (2009) Curcumin suppresses the paclitaxel-induced nuclear factor-κB in breast cancer cells and potentiates the growth inhibitory effect of paclitaxel in a breast cancer nude mice model (pp. 223-229) https://doi.org/10.1111/j.1524-4741.2009.00709.x
  21. Kelemen (2006) The role of folate receptor α in cancer development, progression and treatment: cause, consequence or innocent bystander? (pp. 243-250) https://doi.org/10.1002/ijc.21712
  22. Khodabandehloo et al. (2016) Nanocarriers usage for drug delivery in cancer therapy https://doi.org/10.17795/ijcp-3966
  23. Kolhatkar et al. (2013) Tuning the magnetic properties of nanoparticles (pp. 15977-16009) https://doi.org/10.3390/ijms140815977
  24. Koutras et al. (2008) Myelotoxicity as a prognostic factor in patients with advanced breast cancer treated with chemotherapy: a pooled analysis of two randomised trials conducted by the Hellenic Cooperative Oncology Group (pp. 2913-2920)
  25. Kuttan et al. (1985) Potential anticancer activity of turmeric (Curcuma longa) (pp. 197-202) https://doi.org/10.1016/0304-3835(85)90159-4
  26. Li et al. (2012) Photoinduced electron transfer in folic acid investigated by ultrafast infrared spectroscopy (pp. 3467-3475) https://doi.org/10.1021/jp300392a
  27. Lin et al. (2009) Folic acid–Pluronic F127 magnetic nanoparticle clusters for combined targeting, diagnosis, and therapy applications (pp. 5114-5124) https://doi.org/10.1016/j.biomaterials.2009.06.004
  28. Liu et al. (2009) Folic acid conjugated nanoparticles of mixed lipid monolayer shell and biodegradable polymer core for targeted delivery of Docetaxel (pp. 330-338) https://doi.org/10.1016/j.biomaterials.2009.09.036
  29. Locasale (2013) Serine, glycine and one-carbon units: cancer metabolism in full circle (pp. 572-583) https://doi.org/10.1038/nrc3557
  30. Lomis et al. (2016) Human serum albumin nanoparticles for use in cancer drug delivery: process optimization and in vitro characterization https://doi.org/10.3390/nano6060116
  31. Longley and Johnston (2005) Molecular mechanisms of drug resistance (pp. 275-292) https://doi.org/10.1002/path.1706
  32. Lu et al. (2007) Magnetic nanoparticles: synthesis, protection, functionalization, and application (pp. 1222-1244) https://doi.org/10.1002/anie.200602866
  33. Ma and Mumper (2013) Paclitaxel nano-delivery systems: a comprehensive review https://doi.org/10.4172/2157-7439.1000164
  34. Mudshinge et al. (2011) Nanoparticles: emerging carriers for drug delivery (pp. 129-141) https://doi.org/10.1016/j.jsps.2011.04.001
  35. Pace et al. (2007) Peripheral neurotoxicity of weekly paclitaxel chemotherapy: a schedule or a dose issue? (pp. 550-554) https://doi.org/10.3816/CBC.2007.n.010
  36. Pankhurst et al. (2003) Applications of magnetic nanoparticles in biomedicine (pp. R167-R181) https://doi.org/10.1088/0022-3727/36/13/201
  37. Plank et al. (2003) Magnetofection: enhancing and targeting gene delivery with superparamagnetic nanoparticles and magnetic fields (pp. 29-32) https://doi.org/10.1081/LPR-120017486
  38. Prijic et al. (2010) Increased cellular uptake of biocompatible superparamagnetic iron oxide nanoparticles into malignant cells by an external magnetic field (pp. 167-179) https://doi.org/10.1007/s00232-010-9271-4
  39. Raut et al. (2010) The formulation, characterization and in vivo evaluation of a magnetic carrier for brain delivery of NIR dye https://doi.org/10.1088/0957-4484/21/39/395102
  40. Saul et al. (2003) Controlled targeting of liposomal doxorubicin via the folate receptor in vitro (pp. 49-67) https://doi.org/10.1016/S0168-3659(03)00295-5
  41. Shishodia et al. (2005) Curcumin: getting back to the roots (pp. 206-217) https://doi.org/10.1196/annals.1352.010
  42. Slowing et al. (2009) Mesoporous silica nanoparticles for reducing hemolytic activity towards mammalian red blood cells (pp. 57-62) https://doi.org/10.1002/smll.200800926
  43. Song et al. (2010) Anti-HIF-1α antibody-conjugated pluronic triblock copolymers encapsulated with paclitaxel for tumor targeting therapy (pp. 2302-2312) https://doi.org/10.1016/j.biomaterials.2009.11.067
  44. Sudimack and Lee (2000) Targeted drug delivery via the folate receptor (pp. 147-162) https://doi.org/10.1016/S0169-409X(99)00062-9
  45. Sui et al. (2013) Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment (pp. e838-e838) https://doi.org/10.1038/cddis.2013.350
  46. Sun et al. (2006) Folic acid-PEG conjugated superparamagnetic nanoparticles for targeted cellular uptake and detection by MRI (pp. 550-557) https://doi.org/10.1002/jbm.a.30781
  47. Sun et al. (2008) Magnetic nanoparticles in MR imaging and drug delivery (pp. 1252-1265) https://doi.org/10.1016/j.addr.2008.03.018
  48. ten Tije et al. (2003) Pharmacological effects of formulation vehicles (pp. 665-685) https://doi.org/10.2165/00003088-200342070-00005
  49. Tian et al. (2016) Curcumin suppresses 4-hydroxytamoxifen resistance in breast cancer cells by targeting SLUG/Hexokinase 2 pathway (pp. 147-153) https://doi.org/10.1016/j.bbrc.2016.03.067
  50. Veiseh et al. (2010) Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging (pp. 284-304) https://doi.org/10.1016/j.addr.2009.11.002
  51. Wahajuddin (2012) Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers https://doi.org/10.2147/IJN.S30320
  52. Wallace et al. (2012) Drug release from nanomedicines: selection of appropriate encapsulation and release methodology (pp. 284-292) https://doi.org/10.1007/s13346-012-0064-4
  53. Wang et al. (2007) Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines (pp. 63-73) https://doi.org/10.1016/j.ijpharm.2006.12.033
  54. Wu et al. (2011) Solvothermal synthesis of cobalt ferrite nanoparticles loaded on multiwalled carbon nanotubes for magnetic resonance imaging and drug delivery (pp. 3496-3504) https://doi.org/10.1016/j.actbio.2011.05.031
  55. Xia and Low (2010) Folate-targeted therapies for cancer (pp. 6811-6824) https://doi.org/10.1021/jm100509v
  56. Yallapu et al. (2011) Multi-functional magnetic nanoparticles for magnetic resonance imaging and cancer therapy (pp. 1890-1905) https://doi.org/10.1016/j.biomaterials.2010.11.028
  57. Yallapu et al. (2012) Curcumin nanoformulations: a future nanomedicine for cancer (pp. 71-80) https://doi.org/10.1016/j.drudis.2011.09.009
  58. Zähres et al. (2006) Properties of a water-soluble paclitaxel conjugate in aqueous solution and its interaction with serum albumin (pp. 28-46) https://doi.org/10.1002/masy.200590023
  59. Zhang et al. (2011) Multifunctional Pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors (pp. 2894-2906) https://doi.org/10.1016/j.biomaterials.2010.12.039
  60. Zhao et al. (2008) Targeted drug delivery via folate receptors (pp. 309-319) https://doi.org/10.1517/17425247.5.3.309